Merck Pins Hopes on China's Rising Innovation Tide

Germany-based Merck, a science and technology giant, sees growing opportunities for long-term growth and innovation collaboration in China. According to Rogier Janssens, president of Merck China, China's market not only absorbs innovation but accelerates it.

Janssens pointed to solid momentum in high-end manufacturing and resilient trade in high-value-added products as evidence of China's economic resilience. The country's GDP grew 4.7% year-on-year in the first half to 69.57 trillion yuan ($10.3 trillion), with value-added output of high-tech manufacturing rising 13.3%.

Merck has invested nearly 7 billion yuan in China over the past decade and now sees it as its second-largest market globally. The company's recent investments include expanding high-purity reagent production capacity in Nantong, Jiangsu province, and upgrading its M Lab Collaboration Center in Shanghai.